Healthcare -
Biotechnology - NASDAQ - US
$ 22.285
4.77 %
$ 1.09 B
Market Cap
-11.79
P/E
ELVN - OTHER FINANCING ACTIVITIES
Other Financing Activities ELVN - Enliven Therapeutics, Inc.
234 M
LAST VALUE
1280.71%
2 YEAR CAGR
104.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR